Berger Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$244K Sell
4,029
-181
-4% -$10.6K 0.01% 405
2025
Q4
$227K Sell
4,210
-1,055
-20% -$50.8K 0.01% 428
2025
Q3
$237K Sell
5,265
-1,172
-18% -$54.7K 0.01% 396
2025
Q2
$298K Sell
6,437
-1,293
-17% -$63.5K 0.02% 341
2025
Q1
$471K Sell
7,730
-96,292
-93% -$5.61M 0.03% 266
2024
Q4
$5.88M Buy
104,022
+1,498
+1% +$83.7K 0.41% 57
2024
Q3
$5.3M Buy
102,524
+221
+0.2% +$10.4K 0.38% 63
2024
Q2
$4.25M Buy
102,303
+328
+0.3% +$14.7K 0.34% 80
2024
Q1
$5.53M Buy
101,975
+96,304
+1,698% +$4.91M 0.46% 56
2023
Q4
$291K Sell
5,671
-783
-12% -$41.1K 0.03% 234
2023
Q3
$375K Sell
6,454
-253
-4% -$15.5K 0.04% 180
2023
Q2
$429K Sell
6,707
-70
-1% -$4.69K 0.05% 174
2023
Q1
$470K Buy
6,777
+657
+11% +$46.3K 0.06% 162
2022
Q4
$440K Sell
6,120
-105
-2% -$7.92K 0.06% 165
2022
Q3
$443K Buy
6,225
+163
+3% +$11.8K 0.07% 151
2022
Q2
$467K Sell
6,062
-136
-2% -$10.4K 0.07% 145
2022
Q1
$453K Sell
6,198
-164
-3% -$11K 0.06% 155
2021
Q4
$397K Buy
6,362
+2,564
+68% +$150K 0.05% 176
2021
Q3
$225K Buy
3,798
+197
+5% +$13K 0.04% 191
2021
Q2
$241K Sell
3,601
-415
-10% -$27.1K 0.04% 182
2021
Q1
$254K Sell
4,016
-80
-2% -$4.98K 0.06% 164
2020
Q4
$254K Buy
+4,096
New +$252K 0.04% 177

Other funds holding BMY

Berger Financial Group's BMY Position: Q1 2026 in Review

Berger Financial Group reduced its Bristol-Myers Squibb (BMY) stake by 4.3% in Q1 2026, selling an estimated $10.6K and leaving 4,029 shares worth $244K. The position accounts for 0.01% of the portfolio, ranked #405.

Berger Financial Group first reported a position in BMY in Q4 2020 and has held it in 22 quarters since. The position peaked at $5.88M in Q4 2024. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Berger Financial Group held 4,029 shares of Bristol-Myers Squibb worth $244K as of Q1 2026.
  • Berger Financial Group sold 181 Bristol-Myers Squibb shares in Q1 2026, an estimated $10.6K.
  • Bristol-Myers Squibb made up 0.01% of Berger Financial Group's portfolio in Q1 2026, its #405 holding.
  • Berger Financial Group first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 22 quarters since.
  • Berger Financial Group's Bristol-Myers Squibb position peaked at $5.88M in Q4 2024.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Berger Financial Group's 13F filing for Q1 2026, filed 28 Apr 2026.